Lipid and C-reactive Protein Levels as Risk Factors for Hearing Loss in Older Adults

被引:35
|
作者
Simpson, Annie N. [1 ,2 ]
Matthews, Lois J. [2 ]
Dubno, Judy R. [2 ]
机构
[1] Med Univ S Carolina, Dept Healthcare Leadership & Management, Charleston, SC 29425 USA
[2] Med Univ S Carolina, Dept Otolaryngol Head & Neck Surg, Charleston, SC 29425 USA
基金
美国国家卫生研究院;
关键词
age-related hearing loss; cardiovascular disease; lipid levels; C-reactive protein; DISEASE; ATORVASTATIN; ASSOCIATIONS; CHOLESTEROL; THRESHOLDS; HEALTH; AGE;
D O I
10.1177/0194599812473936
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Objective. To determine the role of cardiovascular disease (CVD) markers, lipids and C-reactive protein, in age-related hearing loss over time. Study Design. Prospective cohort study. Setting. Research laboratories at an academic medical center. Subjects and Methods. In total, 837 older adults (mean age 67.5 years) were included. Primary dependent variables were pure-tone thresholds (pure-tone average [PTA]), including "narrow" PTA (0.5, 1, 2, 4 kHz), "broad" PTA (0.5, 1, 2, 3, 4, 6, 8 kHz), low-frequency PTA (0.25, 0.5, 1 kHz), and high-frequency PTA (2, 3, 4, 6, 8 kHz). Repeated-measures mixed regression modeling was used to assess the relationship between C-reactive protein (CRP) and lipid levels with PTAs over time. Results. In a cross-sectional sample of 837 subjects, modest associations were found between triglycerides and all PTAs. Weak associations were observed between the ratio of total cholesterol and high-density lipoprotein and narrow PTA, broad PTA, and high-frequency PTA. However, when assessing changes in hearing and lipids over time in a longitudinal analysis, no significant associations between hearing and lipids remained. PTAs and CRP were not statistically associated when controlling for age and sex. Conclusion. Associations between hearing and blood lipids have been the focus of scientific inquiry for more than 50 years. The current results suggest that the association is either spurious or too small to be of consequence in the assessment and treatment of hearing loss in older adults. Inquiry into other potential risk factors for age-related hearing loss and associations with CVD may prove more fruitful.
引用
收藏
页码:664 / 670
页数:7
相关论文
共 50 条
  • [41] High-sensitivity C-reactive protein and mobility disability in older adults
    Verghese, Joe
    Holtzer, Roee
    Lipton, Richard B.
    Wang, Cuiling
    AGE AND AGEING, 2012, 41 (04) : 541 - 545
  • [42] Racial Differences in Elevated C-Reactive Protein Among US Older Adults
    Farmer, Heather R.
    Wray, Linda A.
    Xian, Ying
    Xu, Hanzhang
    Pagidipati, Neha
    Peterson, Eric D.
    Dupre, Matthew E.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2020, 68 (02) : 362 - 369
  • [43] Response of C-reactive protein and serum amyloid a to influenza A infection in older adults
    Falsey, AR
    Walsh, EE
    Francis, CW
    Looney, RJ
    Kolassa, JE
    Hall, WJ
    Abraham, GN
    JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (07): : 995 - 999
  • [44] Increased Serum C-reactive Protein and Corpus Callosum Alterations in Older Adults
    Cyprien, Fabienne
    Courtet, Philippe
    Maller, Jerome
    Meslin, Chantal
    Ritchie, Karen
    Ancelin, Marie-Laure
    Artero, Sylvaine
    AGING AND DISEASE, 2019, 10 (02): : 463 - 469
  • [45] C-REACTIVE PROTEIN AND RESISTANCE EXERCISE TRAINING IN COMMUNITY DWELLING OLDER ADULTS
    Chang, M.
    Ramel, A.
    Geirsdottir, O. G.
    Arnarson, A.
    Jonsson, P. V.
    Thorsdottir, I.
    GERONTOLOGIST, 2013, 53 : 575 - 576
  • [46] Effects of statins and/or fibrates on C-reactive protein and lipid levels in metabolic syndrome
    Reiber, I
    Mezö, I
    ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (01) : 119 - 119
  • [47] C-reactive protein levels and cardiovascular risk after statin therapy
    Nature Clinical Practice Cardiovascular Medicine, 2005, 2 (3): : 118 - 118
  • [48] Asthma is an independent risk for elevation of plasma C-reactive protein levels
    Kasayama, Soji
    Tanemura, Mari
    Koga, Masafumi
    Fujita, Kimie
    Yamamoto, Hiroyasu
    Miyatake, Akihiko
    CLINICA CHIMICA ACTA, 2009, 399 (1-2) : 79 - 82
  • [49] C-reactive protein levels in patients at cardiovascular risk: EURIKA study
    Halcox, Julian P. J.
    Roy, Carine
    Tubach, Florence
    Banegas, Jose R.
    Dallongeville, Jean
    De Backer, Guy
    Guallar, Eliseo
    Sazova, Oguen
    Medina, Jesus
    Perk, Joep
    Steg, Philippe Gabriel
    Rodriguez-Artalejo, Fernando
    Borghi, Claudio
    BMC CARDIOVASCULAR DISORDERS, 2014, 14
  • [50] C-reactive protein levels may be a modifiable marker for CV risk
    不详
    GERIATRICS, 1999, 54 (09) : 17 - 17